U.S. drug pricing watchdog gets funding to expand efforts

This post was originally published on this site

(Reuters) – A U.S. independent nonprofit organization that evaluates the clinical and cost effectiveness of new medicines said on Tuesday it has received significant new funding that will enable it to greatly expand its work.